The United States Bone Growth Stimulator Industry is poised to witness an unprecedented surge with projections exceeding a remarkable USD 2.2 billion by the year 2033. This substantial growth can be attributed to several key factors, including the widespread adoption of cutting-edge bone growth stimulator devices, a notable increase in bone-related ailments, the presence of prominent manufacturers within the nation, and various other contributing factors.
One significant driver of this market expansion is the escalating prevalence of joint conditions, such as osteoporosis, arthritis, and rheumatoid arthritis, among others. The United States is experiencing a rise in these debilitating conditions, creating a favorable climate for the bone growth stimulator market’s robust growth.
The confluence of these elements is set to redefine the landscape of bone growth stimulator devices in the United States, offering a brighter and more promising future for patients in need of advanced and effective solutions. The industry’s rapid evolution underscores the significance of innovative technologies and treatments in addressing bone health, leading to a healthier and more active nation.
Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-828
The Global Bone Growth Stimulators Market size is predicted to be worth US$ 2.1 billion in 2023, rising to US$ 5.4 billion by 2033. During the projected period, sales of Bone Growth stimulants are expected to expand at a substantial CAGR of 10.1%. Growth in the market is attributed to the rising overall fracture injuries around the world which are expected to propel the demand for Bone Growth Stimulators over the upcoming years.
The rising prevalence of bone and joint issues, the increased desire for minimally invasive and non-invasive operations internationally, and the growing geriatric population are driving the market for Bone Growth Stimulators.
A bone growth stimulator’s best advantage is that it accelerates the entire process of bone healing, resulting in faster recovery, shorter hospitalisation, higher cost-effectiveness, and fewer infections.
According to a recent study conducted by the International Osteoporosis Foundation, statistics revealed that more than200 a million people are suffering from osteoporosis. Worldwide, 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporotic fractures in their lifetime. These numbers are anticipated to increase at a fast pace in the assessment period, therefore, bolstering the demand for Bone Growth Stimulators worldwide.
Key Takeaways
- Because of an ageing population, rapid economic expansion in growing Asia-Pacific (APAC) countries, and an increase in the volume of spine surgeries, the Bone Growth Stimulators market in numerous Asia-Pacific countries is likely to grow rapidly over the forecast period.
- India is predicted to be the fastest-growing market in APAC, with a CAGR of 11.4%. Growth will be fueled by improvements in the country’s healthcare landscape.
- The US market for Bone Growth Stimulators is estimated to exceed US$ 2.2 billion by 2033.
- With a rise in medical tourism and a growing demand for less invasive procedures, the United Kingdom is expected to dominate the European Bone Growth Stimulators market in the next years. Sales are expected to account for 20.4% of the global market in 2022.
- The hospital segment is estimated to be valued more than US$ 743 million by 2028.
Competitive Landscape
The prominent players operating in the global Bone Growth Stimulators market are extensively investing in research and development activities in order to launch innovative and technologically advanced products that cater to an expanding customer base. In addition to that, dominant market players are heavily investing in mergers, acquisitions, collaborations, and partnerships to strengthen their distribution networks.
Methodology Details Just a Click Away!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-828
Some of the leading companies operating in the Bone Growth Stimulators Market are
- Zimmer Biomet Holdings Inc
- Bioventus LLC.
- DJO Global, Orthofix Holdings, Inc.
- Ossatec Benelux Ltd.
- IGEA
- Ito Co., Ltd.
More Insights into the Bone Growth Stimulators Market
The US is expected to dominate the North American region by garnering maximum sales in the global Bone Growth Stimulators market. The global market is anticipated to account for about 42.5% of the total market share in 2022. According to the CDC, around 1 out of every 4 US adults (23.7%, 58.5 million people) suffer from diagnosed arthritis. The incidence of arthritis and osteoarthritis is predicted to grow in the forthcoming years, which in turn will propel the demand for electrical Bone Growth Stimulators over the assessment period.
The UK is predicted to dominate the European Bone Growth Stimulators market in the forthcoming years, as it accounts for around 20.4% of the total market share in 2022. The growth is attributed to the growing preference for minimally invasive procedures and the rising popularity of medical tourism in the country.
Tap into Comprehensive Segmented Information Purchase Now!
https://www.futuremarketinsights.com/checkout/828
Bone Growth Stimulators Markets by Category
Product Type:
- Non-Invasive Bone Growth Stimulators
- Capacitive Coupling (CC) Devices
- Pulsed Electromagnetic Field (PEMF) Devices
- Combined Magnetic Field (CMF) Devices
- Ultrasound Bone Growth Stimulators
- Invasive Bone Growth Stimulators
Application:
- Trauma Injury and Fractures
- Spinal Fusion
- Osteogenesis
End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
- Homecare settings
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
